US · NVST
Envista Holdings Corp
- Sector
- Healthcare · Medical - Equipment & Services
- Headquarters
- Brea, CA 92821-6208
- Website
- envistaco.com
Price · as of 2025-12-31
$26.33
Market cap 4.8B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $46.42 | +76.3% |
| Intrinsic Value(DCF) | $15.57 | -40.87% |
| Graham-Dodd Method(GD) | $5.85 | -77.77% |
| Graham Formula(GF) | $4.52 | -82.83% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | $17.15 | $13.85 | |||
| 2019 | $22.48 | $44.07 | $1.24 | $9.71 | $0.00 |
| 2020 | $40.75 | $43.96 | $8.20 | $4.26 | $0.00 |
| 2021 | $45.06 | $84.27 | $16.24 | $16.30 | $77.79 |
| 2022 | $37.44 | $72.77 | $3.89 | $11.82 | $15.56 |
| 2023 | $21.23 | $36.35 | $1.31 | $2.28 | $0.00 |
| 2024 | $18.43 | $22.64 | $0.00 | $0.00 | $0.00 |
| 2025 | $29.44 | $46.42 | $7.06 | $5.85 | $4.52 |
AI valuation
Our deep-learning model estimates Envista Holdings Corp's (NVST) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $46.42
- Current price
- $26.33
- AI upside
- +76.3%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$15.57
-40.87% upside
Graham-Dodd
$5.85
-77.77% upside
Graham Formula
$4.52
-82.83% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| NVST | Envista Holdings Corp | $26.33 | 4.8B | +76% | -41% | -78% | -83% | 105.23 | 1.59 | 1.82 | 15.93 | — | 40.91 | 55.02% | 8.30% | 1.73% | 1.56% | 2.57% | 0.85% | 0.55 | 6.17 | 2.38 | 1.93 | 1.45 | -10431.00% | 832.00% | -2389.00% | 4.66% | 0.32 | 6.57% | 0.00% | 0.00% | 3.37% | 24.11 | 23.62 | 2.00 | 1.90 |
| ALHC | Alignment Healthcare, Inc… | $19.22 | 3.85B | +83% | +12,068% | -96% | — | -5374.06 | 21.70 | 0.99 | 73.41 | — | 27.27 | 12.37% | 0.37% | -0.02% | -0.52% | -6.84% | -0.08% | 0.04 | 0.93 | 1.71 | 1.49 | -12.58 | -9945.00% | 4606.00% | -220480.00% | 3.60% | 0.25 | -64.84% | 0.00% | 0.00% | 11.97% | 225.15 | 23.74 | 0.84 | 5.50 |
| APGE | Apogee Therapeutics, Inc. | $70.00 | 3.84B | — | — | — | — | -10.95 | 2.78 | — | -6.86 | -11.08 | 2.78 | 0.00% | — | — | -33.22% | -223.05% | -31.53% | 0.02 | — | 18.55 | 18.39 | 0.60 | 9880.00% | — | 12999.00% | -8.64% | -5.99 | -177.24% | 0.00% | 0.00% | 0.69% | -6.85 | -8.62 | — | 31.49 |
| CON | Concentra Group Holdings … | $23.96 | 3.07B | +123% | -60% | — | +21% | 17.38 | 7.64 | 1.39 | 8.47 | — | -2.26 | 28.34% | 96.50% | 7.99% | 51.66% | 111.32% | 6.42% | 1.37 | 19.10 | 1.14 | 1.00 | 1.12 | 0.00% | 1385.00% | 3283.00% | 9.30% | 0.83 | 19.29% | 0.00% | 0.00% | 43.58% | 1.66 | 12.39 | 1.60 | 4.00 |
| DYN | Dyne Therapeutics, Inc. | $15.62 | 2.57B | — | — | — | — | -3.68 | 1.85 | — | -1.74 | — | 1.85 | 0.00% | — | — | -88.03% | -9599.05% | -74.14% | 0.04 | — | 15.60 | 15.20 | 1.31 | -1468.00% | — | 5604.00% | -25.25% | -6.92 | -8227.36% | 0.00% | 0.00% | 27.18% | -1.60 | -1.86 | — | 8.91 |
| GRAL | GRAIL, Inc. | $53.23 | 2.08B | -54% | -60% | -73% | — | — | 0.75 | 13.14 | -2.99 | — | 2.66 | -42.52% | -362.95% | -277.47% | 0.00% | -22.80% | 0.00% | 0.04 | — | 11.97 | 11.58 | 0.40 | -8251.00% | 1718.00% | -4866.00% | -15.46% | -3.75 | -16.71% | 0.00% | — | 0.29% | -2.11 | -3.77 | 7.66 | -1.71 |
| ICUI | ICU Medical, Inc. | $150.58 | 3.72B | -14% | -61% | -83% | -100% | 4947.86 | 1.71 | 1.62 | 14.41 | — | -381.73 | 36.76% | 4.80% | 0.03% | 0.04% | 1.32% | 0.02% | 0.66 | 1.01 | 2.36 | 0.98 | 3.32 | -10061.00% | -638.00% | -2636.00% | 2.53% | 0.36 | 2.82% | 0.00% | 0.00% | 7.11% | 44.00 | 51.26 | 2.11 | 2.21 |
| PRVA | Privia Health Group, Inc. | $23.75 | 2.92B | +1,602% | +12,603% | +22,024% | +23,094% | 0.10 | 0.00 | 1.38 | -8677.07 | 0.16 | 0.01 | 9.40% | 1.61% | 1079.64% | 8.06% | 0.02% | 4.34% | 0.01 | — | 1.60 | 1.55 | -8731.62 | 6364.00% | 2226.00% | 15646682.00% | 5557.73% | 0.29 | 122.18% | 0.00% | 0.00% | 15990.70% | -13647.35 | -2.86 | -220.09 | 0.14 |
| RARE | Ultragenyx Pharmaceutical… | $23.39 | 2.26B | -15% | -61% | — | — | -3.95 | -28.37 | 3.37 | -5.71 | — | -7.57 | 83.80% | -79.49% | -85.44% | -656.03% | -567.31% | -37.89% | -15.95 | -8.63 | 2.48 | 2.22 | -1.68 | -731.00% | 2013.00% | 1193.00% | -20.80% | -1.21 | -500.50% | 0.00% | 0.00% | 0.00% | -5.33 | -6.04 | 4.24 | -3.56 |
| SUPN | Supernus Pharmaceuticals,… | $54.73 | 3.14B | +101% | -41% | -57% | -59% | 23.92 | 1.71 | 2.67 | 7.56 | 0.44 | 4.45 | 88.23% | 12.34% | 11.16% | 7.55% | 9.31% | 5.58% | 0.03 | — | 2.35 | 2.04 | -0.20 | 546962.00% | 894.00% | 5491.00% | 9.69% | 0.59 | 25.85% | 0.00% | 0.00% | 0.09% | 16.50 | 7.87 | 2.04 | 4.79 |
| XRAY | DENTSPLY SIRONA Inc. | $14.68 | 2.93B | +40% | -61% | — | — | -4.77 | 2.13 | 0.78 | -107.57 | — | -3.65 | 50.00% | 6.85% | -16.25% | -36.44% | 6.83% | -10.70% | 1.81 | 2.86 | 1.51 | 0.76 | -45.54 | -3304.00% | -298.00% | -6299.00% | 3.64% | 0.17 | 2.82% | 4.49% | -21.40% | 4.49% | 19.64 | 47.58 | 1.34 | 1.00 |
About Envista Holdings Corp
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
- CEO
- Paul A. Keel
- Employees
- 12.3K
- Beta
- 1.00
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($15.57 ÷ $26.33) − 1 = -40.87% (DCF, example).